Matches in SemOpenAlex for { <https://semopenalex.org/work/W2036169665> ?p ?o ?g. }
- W2036169665 endingPage "394" @default.
- W2036169665 startingPage "387" @default.
- W2036169665 abstract "The aim of the study was to assess the effects of the combination of metformin plus pioglitazone or rosiglitazone on glucose and blood pressure in type 2 diabetic patients with metabolic syndrome, as well as its tolerability in those patients. In this 12-month, multicentric, double-blind, randomized, controlled, parallel-group trial, all patients began with metformin. Patients were randomized for self-administration of either pioglitazone or rosiglitazone for 12 months. We assessed body mass index (BMI), glycemic control (glycosylated hemoglobin [HbA(1c)], fasting and postprandial plasma glucose and insulin levels [FPG, PPG, FPI and PPI, respectively] and homeostasis model assessment [HOMA] index) and systolic and diastolic blood pressure (SBP and DBP, respectively), at baseline and at 3, 6, 9 and 12 months of treatment, as well as high-sensitivity C-reactive protein (hs-CRP), nitrites/nitrates and adiponectin (ADN) at baseline and at 12 months of treatment. Significant HbA(1c) decreases were obtained after 9 (p<0.05) and 12 (p<0.01) months in both groups. After 9 and 12 months, mean FPG and PPG levels were decreased in both groups (p<0.05 and p<0.01, respectively). We observed decreases in FPI and PPI at 9 and 12 months (p<0.05 and p<0.01, respectively) compared to the baseline values in both groups. Furthermore, HOMA index improvement over the baseline value was obtained only at 12 months (p<0.05) in both groups. SBP and DBP improved significantly (p<0.05, for each) in both groups after 12 months. hs-CRP decreased significantly (p<0.05) in both groups after 12 months; nitrites/nitrates and ADN increased significantly (p<0.05, for each) in both groups after 12 months. The combination of thiazolinediones and metformin is associated with a slight but significant improvement in the long-term blood pressure control of these patients, and with an improvement in the anti-inflammatory state, both of which are related to a similar reduction in insulin-resistance." @default.
- W2036169665 created "2016-06-24" @default.
- W2036169665 creator A5021841408 @default.
- W2036169665 creator A5030775648 @default.
- W2036169665 creator A5038668185 @default.
- W2036169665 creator A5042943056 @default.
- W2036169665 creator A5044628820 @default.
- W2036169665 creator A5049126629 @default.
- W2036169665 creator A5049217502 @default.
- W2036169665 creator A5050662641 @default.
- W2036169665 creator A5068440626 @default.
- W2036169665 creator A5085734415 @default.
- W2036169665 creator A5088019145 @default.
- W2036169665 date "2007-01-01" @default.
- W2036169665 modified "2023-10-16" @default.
- W2036169665 title "Blood Pressure Control and Inflammatory Markers in Type 2 Diabetic Patients Treated with Pioglitazone or Rosiglitazone and Metformin" @default.
- W2036169665 cites W1587875569 @default.
- W2036169665 cites W1963886325 @default.
- W2036169665 cites W1964116075 @default.
- W2036169665 cites W1964716328 @default.
- W2036169665 cites W1978492951 @default.
- W2036169665 cites W1985123503 @default.
- W2036169665 cites W1990802251 @default.
- W2036169665 cites W1996896137 @default.
- W2036169665 cites W2000378161 @default.
- W2036169665 cites W2006900177 @default.
- W2036169665 cites W2023549874 @default.
- W2036169665 cites W2039401819 @default.
- W2036169665 cites W2045975885 @default.
- W2036169665 cites W2057651652 @default.
- W2036169665 cites W2107166617 @default.
- W2036169665 cites W2138470202 @default.
- W2036169665 cites W2148322270 @default.
- W2036169665 cites W2158822657 @default.
- W2036169665 cites W2160234571 @default.
- W2036169665 cites W2163498104 @default.
- W2036169665 cites W2188846692 @default.
- W2036169665 cites W2345903479 @default.
- W2036169665 cites W3080346889 @default.
- W2036169665 cites W4214772579 @default.
- W2036169665 cites W4238251256 @default.
- W2036169665 cites W4249622238 @default.
- W2036169665 doi "https://doi.org/10.1291/hypres.30.387" @default.
- W2036169665 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17587750" @default.
- W2036169665 hasPublicationYear "2007" @default.
- W2036169665 type Work @default.
- W2036169665 sameAs 2036169665 @default.
- W2036169665 citedByCount "50" @default.
- W2036169665 countsByYear W20361696652013 @default.
- W2036169665 countsByYear W20361696652014 @default.
- W2036169665 countsByYear W20361696652015 @default.
- W2036169665 countsByYear W20361696652016 @default.
- W2036169665 countsByYear W20361696652017 @default.
- W2036169665 countsByYear W20361696652018 @default.
- W2036169665 countsByYear W20361696652020 @default.
- W2036169665 countsByYear W20361696652021 @default.
- W2036169665 crossrefType "journal-article" @default.
- W2036169665 hasAuthorship W2036169665A5021841408 @default.
- W2036169665 hasAuthorship W2036169665A5030775648 @default.
- W2036169665 hasAuthorship W2036169665A5038668185 @default.
- W2036169665 hasAuthorship W2036169665A5042943056 @default.
- W2036169665 hasAuthorship W2036169665A5044628820 @default.
- W2036169665 hasAuthorship W2036169665A5049126629 @default.
- W2036169665 hasAuthorship W2036169665A5049217502 @default.
- W2036169665 hasAuthorship W2036169665A5050662641 @default.
- W2036169665 hasAuthorship W2036169665A5068440626 @default.
- W2036169665 hasAuthorship W2036169665A5085734415 @default.
- W2036169665 hasAuthorship W2036169665A5088019145 @default.
- W2036169665 hasBestOaLocation W20361696651 @default.
- W2036169665 hasConcept C126322002 @default.
- W2036169665 hasConcept C134018914 @default.
- W2036169665 hasConcept C197934379 @default.
- W2036169665 hasConcept C2776782570 @default.
- W2036169665 hasConcept C2777180221 @default.
- W2036169665 hasConcept C2777391703 @default.
- W2036169665 hasConcept C2778199505 @default.
- W2036169665 hasConcept C2778375690 @default.
- W2036169665 hasConcept C2778384471 @default.
- W2036169665 hasConcept C2779306644 @default.
- W2036169665 hasConcept C2780152017 @default.
- W2036169665 hasConcept C2780221984 @default.
- W2036169665 hasConcept C2780323712 @default.
- W2036169665 hasConcept C2780473172 @default.
- W2036169665 hasConcept C555293320 @default.
- W2036169665 hasConcept C71924100 @default.
- W2036169665 hasConcept C84393581 @default.
- W2036169665 hasConcept C90924648 @default.
- W2036169665 hasConceptScore W2036169665C126322002 @default.
- W2036169665 hasConceptScore W2036169665C134018914 @default.
- W2036169665 hasConceptScore W2036169665C197934379 @default.
- W2036169665 hasConceptScore W2036169665C2776782570 @default.
- W2036169665 hasConceptScore W2036169665C2777180221 @default.
- W2036169665 hasConceptScore W2036169665C2777391703 @default.
- W2036169665 hasConceptScore W2036169665C2778199505 @default.
- W2036169665 hasConceptScore W2036169665C2778375690 @default.
- W2036169665 hasConceptScore W2036169665C2778384471 @default.
- W2036169665 hasConceptScore W2036169665C2779306644 @default.
- W2036169665 hasConceptScore W2036169665C2780152017 @default.